Democrats promise an 'orderly process' to replace Biden. Harris is favored, but questions remain

WASHINGTON (AP) — Shortly after President Joe Biden announced that he would drop his reelection campaign, Democratic National Committee Chair Jaime Harrison had a message: There would be no automatic coronation for his replacement.

“In the coming days, the party will undertake a transparent and orderly process to move forward,” Harrison said in a statement. “This process will be governed by established rules and procedures of the party. Our delegates are prepared to take seriously their responsibility in swiftly delivering a candidate to the American people.“

The comment reflected the reality that while Vice President Kamala Harris is emerging as the prohibitive favorite to become the party's nominee — backed already by Biden and many Democrats — it's not so simple. And, for now, the party isn't offering many details on what happens next.

Some DNC members had already begun privately discussing contingency plans for the possibility that Biden would step aside prior to his decision to formally do so on Sunday, and a committee setting the party’s rules for the Democratic National Convention, which opens Aug. 19 in Chicago, will gather virtually on Wednesday afternoon to discuss the next steps.

Harris has to formally secure the nomination from the around 4,700 Democratic convention delegates — including those pledged to Biden, as well as the elected officials, former presidents and other party elders known as superdelegates. She spent part of Sunday calling elected officials and delegates to solidify their support.

Biden won Democratic primaries in every state, and Harris was on the ticket as his running mate. His tapping her as his successor while bowing out of the race further strengthens her case, as does the endorsements of party heavyweights like South Carolina Rep. Jim Clyburn. Other top Democrats openly backed the vice president even before Biden abandoned his reelection bid, urging him to “pass the torch” to her in the wake of his dismal debate performance against Republican nominee Donald Trump last month.

“Folks will be weighing in and they should. I think we’re seeing a lot of coalescing behind the vice president,” said Rahna Epting, executive director of the progressive organization MoveOn. “And that's important because, as we saw throughout the Biden debate fallout, there is momentum that can be built one way or the other, and it is important for us to build momentum toward unity.”

Ken Martin, president of the Association of State Democratic Committees, which represents the 57 parties in the states and territories, said Harris was the obvious choice: “Having served alongside President Biden, she is ready on day one as a candidate and as our next president.” She was also endorsed by the 1.75-million-member American Federation of Teachers union.

But Democratic rules state only that delegates “in all good conscience” vote for the candidate they were elected to represent, with no mechanism for defectors. And some in the party have endorsed an open nominating process.

There’s been active debate about how to proceed among lawmakers, major donors and former high-ranking officials of the Biden, Obama and Clinton administrations, said a Democrat with deep ties to the Biden administration.

The person, who spoke on the condition of anonymity to discuss internal conversations, argued that Harris would benefit from a competitive mini-primary ahead of the Democratic convention, because it would help solidify her as a strong candidate and diminish criticism that she’s been undemocratically anointed. That's a charge the Trump campaign has already sought to use against her, and could loom large in the battle for undecided voters in battleground states.

Such a scenario might leave Democrats heading into their convention without a clear nominee, though, and perhaps choosing one via a series of potentially messy floor votes. That could mean top Democratic candidates looking to replace Biden resorting to visiting individual state delegations to lobby — a process unseen since 1960, when Johnson and John F. Kennedy jockeyed for support during their party's convention in Los Angeles.

If that happened, in addition to Harris, many other leading Democrats could vie for the nomination, including the likes of California Gov. Gavin Newsom, Michigan Gov. Gretchen Whitmer, Pennsylvania Gov. Josh Shapiro and California Rep. Ro Khanna — though many of those said shortly after Biden's announcement that they were formally endorsing Harris.

Inside the White House, meanwhile, there’s low expectation that Harris will get a serious challenge, according to a person familiar with deliberations who requested anonymity to discuss the private conversations.

Others who have been mentioned as viable contenders — including Shapiro and North Carolina Gov. Roy Cooper — have also both endorsed Harris and would seem unlikely to run in light of Biden’s backing her, and the expected fundraising advantage she would hold over anyone who’d enter the field.

Further complicating matters is the fact that the DNC had planned to hold a virtual roll call to choose its nominee ahead of the convention, in order to meet Ohio ballot eligibility rules. That state's original deadline ballot deadline was Aug. 7, and though the Legislature has since approved a law nullifying that, it doesn’t take effect until Sept. 1.

DNC lawyers say that means the party could face legal challenges in Ohio if it fails to name their party’s nominee prior to the state’s original deadline. But the convention rules committee has said it won’t set a date for the virtual roll call — which could take place over several days — before Aug. 1.

Some Democrats fear a host of other GOP legal challenges, including New York Rep. Alexandria Ocasio-Cortez, who had defended Biden staying in the race by arguing that replacing him might trigger “a presidential election being decided by Clarence Thomas and the Supreme Court” — like what happened during the 2000 presidential election and the disputed recount in Florida.

At Wednesday's conventions rules committee meeting, members could establish virtual roll call rules and a process to nominate Harris or create a more open process for choosing a nominee, according to a person familiar with the process on condition of anonymity to discuss internal deliberations.

“During the convention, we will have an opportunity to show the country and the world who Democrats are and what we stand for,” Minyon Moore, Democratic convention chair, said in a statement.

Harrison, the DNC chair, refrained from endorsing Harris in a statement, saying only, "In short order, the American people will hear from the Democratic Party on next steps and the path forward for the nomination process.”

A somber Harrison also joined a virtual meeting of the convention credentials committee on Sunday, telling members, “I'm emotional.”

“I still support my president,” Harrison said of Biden. "And we will get through this, my friends, as we always do.”

Associated Press writer Colleen Long contributed to this report.

FILE - President Joe Biden listens as Vice President Kamala Harris speaks in the Rose Garden of the White House in Washington, May 13, 2024. With Biden ending his reelection bid and endorsing Harris, Democrats now must navigate a shift that is unprecedented this late in an election year. Democrats are set to hold their convention in Chicago in August. (AP Photo/Susan Walsh, File)

NEW YORK (AP) — A mural honoring ancient and modern figures in medicine that has hung in the lobby of Pfizer’s original New York City headquarters for more than 60 years could soon end up in pieces if conservationists can’t find a new home for it in the next few weeks.

“Medical Research Through the Ages,” a massive metal and tile mosaic depicting scientists and lab equipment, has been visible through the high glass-windowed lobby of the pharmaceutical giant’s midtown Manhattan office since the 1960s.

But the building is being gutted and converted into residential apartments, and the new owners have given the mural a move-out date of as soon as Sept. 10.

Art conservationists and the late artist’s daughters are now scrambling to find a patron who is able to cover the tens of thousands of dollars they estimate it will take to move and remount it, as well as an institution that can display it.

“I would ideally like to see it as part of an educational future, whether it’s on a hospital campus as part of a school or a college. Or part of a larger public art program for the citizens of New York City,” said art historian and urban planner Andrew Cronson, one of the people trying to find a new home for the piece.

The 40-foot-wide and 18-foot-high (12 meters by 5.5 meters) mural by Greek American artist Nikos Bel-Jon was the main showpiece of Pfizer’s world headquarters when the building opened a few blocks from Grand Central Terminal in 1961, at a time when flashy buildings and grand corporate art projects were a symbol of business success. He died in 1966, leaving behind dozens of large brushed-metal works commissioned by companies and private institutions, many of which have now been lost or destroyed.

In recent years, Pfizer sold the building — and last year moved its headquarters to a shared office space in a newer property. The company said in an emailed statement that it decided the money needed to deconstruct, relocate and reinstall the mural elsewhere would be better spent on “patient-related priorities.”

The developer now turning the building into apartments, Metro Loft, doesn't want to keep the artwork either, though it has been working with those trying to save the piece with help like letting art appraisers in. The company declined to comment further, but Jack Berman, its director of operations, confirmed in an email that it needs to get the mural out.

Bel-Jon’s youngest daughter, Rhea Bel-Jon Calkins, said they’ve gotten some interest from universities who could take the piece, and a Greek cultural organization that could help fundraise for the move. But the removal alone could cost between $20,00 and $50,000, according to estimates cited by Cronson.

If they can’t immediately find a taker, the mural won’t end up in landfill, Bel-Jon Calkins said. But it would have to be broken up into pieces — nine metal sections and eight mosaic sections — and moved into storage, likely with some of her relatives.

Time is ticking away. Workers gutting the building have been carrying out ripped-up carpeting, drab office chairs and piles of scrap wood and loading them into garbage trucks.

For the past few decades, the artwork's metal — brushed tin and aluminum panels in the shape of laboratory beakers, funnels and flasks, surrounded by symbols, alchemists and scientists — has been a dull gray and white. But Bel-Jon Calkins remembers its original, multicolored lighting scheme.

“As you moved, the color moved with you and changed. So there was a constant dynamic to the mural that no one really has ever been able to achieve,” she said.

Richard McCoy, director of the Indiana nonprofit Landmark Columbus Foundation, which cares for local buildings and landscapes, said the piece might lack commercial value, describing Bel-Jon as “extraordinary, but not super well-known.”

“But then you realize 20 or 30 years from then how great it was,” he said, adding that it might merit preservation for its historical value.

Bel-Jon Calkins tracks her father’s 42 large-scale metal murals in a spreadsheet and on the artist's website. She said only about a dozen are confirmed to exist.

A 12-foot (3.6-meter) metal mosaic depicting saints and commissioned by a Greek Orthodox church in San Francisco was destroyed in the Loma Prieta earthquake of 1989. General Motors commissioned a hubcap-shaped metal mural that was larger than a car for a trade show, but she confirmed it was later melted down into scrap.

“It’s the corporations that have lost them,” she said in a phone conversation from her home in San Miguel de Allende, Mexico. “They valued them enough to commission them but not enough to preserve them.”

This undated photo shows the massive "Medical Research Through the Ages" mural at Pfizer's 1961 world headquarters in New York with its original multicolored lighting setup. (Rhea Bel-Jon Calkins via AP)

This undated photo shows Nikos Bel-Jon in his New York Studio on East 72 Street in front of a model of the massive metal mural he built for Pfizer's world headquarters in 1961. (Rhea Bel-Jon Calkins via AP)

An image of Dr. Edward Jenner, who discovered a vaccine for smallpox, is part of a metal mosaic mural created in 1960 by Greek-born artist Nikos Bel-Jon titled "Medical Research Through the Ages," seen in the lobby of the old Pfizer headquarters in New York on Thursday, August 29, 2024. (AP Photo/Ted Shaffrey)

An image of a Sister of St. Martha, representative of women who devoted their lives to nursing the sick; and an image of Andres Vesalius, known as the founder of modern anatomy; are part of a metal mosaic mural created in 1960 by Greek-born artist Nikos Bel-Jon titled "Medical Research Through the Ages," seen in the lobby of the old Pfizer headquarters in New York on Thursday, August 29, 2024. (AP Photo/Ted Shaffrey)

Images, from left, of Horus, Egyptian mythology god; Emperor Shen-Nung; Hippocrates; and Doctor of Salerno; are part of a metal mosaic mural created in 1960 by Greek-born artist Nikos Bel-Jon titled "Medical Research Through the Ages," seen in the lobby of the old Pfizer headquarters in New York on Thursday, August 29, 2024. (AP Photo/Ted Shaffrey)

A metal mosaic mural created in 1960 by Greek-born artist Nikos Bel-Jon and titled "Medical Research Through the Ages" is in the lobby of the old Pfizer headquarters in New York on Thursday, August 29, 2024. (AP Photo/Ted Shaffrey)